Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment

In this meta-analysis, we aimed to estimate and compare the efficacy of add-on treatment of antidepressants with esketamine nasal spray and second-generation antipsychotics in patients with nonpsychotic major depressive disorder and inadequate response to antidepressants. Searching for acute-phase,...

Descripción completa

Detalles Bibliográficos
Autores principales: Dold, Markus, Bartova, Lucie, Kasper, Siegfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387762/
https://www.ncbi.nlm.nih.gov/pubmed/32570275
http://dx.doi.org/10.1093/ijnp/pyaa034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387762/
https://www.ncbi.nlm.nih.gov/pubmed/32570275
http://dx.doi.org/10.1093/ijnp/pyaa034

Ejemplares similares